Pfizer-BioNTech start full U.S. approval application for COVID-19 vaccine – Reuters
1 min read
Pfizer-BioNTech start full U.S. approval application for COVID-19 vaccine – Reuters
Pfizer Inc (PFE.N) and German partner BioNTech SA said on Friday they have started an application process with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccine, currently only authorized for emergency use.